Strategic use of geography (BRIC) in global clinical trials – new perspectives
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentations + Posters
- By: VOINOV, Greg (ICON, Paris, France)
In clinical trials, the geographic expansion is driven by patient availability, especially naïve treatment patients. 40 % of the global population lives in Brazil, Russia, India and China (BRIC). Nowadays, sponsors consider patient enrolment to be the most important factor in clinical trial performance. The health care environment of BRIC.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.